Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sandro B. Rizoli"'
Autor:
Alex P Di Battista, John E Buonora, Shawn G Rhind, Michael Gary Hutchison, Andrew J Baker, Sandro B. Rizoli, Ramon eDiaz-Arrastia, Gregory P Mueller
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
Background: Blood biomarkers are valuable tools for elucidating the complex cellular and molecular mechanisms underlying traumatic brain injury (TBI) pathophysiology. Profiling distinct classes of biomarkers could aid in the identification and charac
Externí odkaz:
https://doaj.org/article/8213791852d542c9bdec4fef6ae623f5
Autor:
John E. Buonora, Angela M. Yarnell, Rachel eLazarus, Michael eMousseau, Lawrence L. Latour, Sandro B. Rizoli, Andrew J Baker, Shawn G. Rhind, Ramon eDiaz-Arrastia, Gregory P. Mueller
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
Important challenges for the diagnosis and monitoring of mild traumatic brain injury (mTBI) include the development of plasma biomarkers for assessing neurologic injury, monitoring pathogenesis and predicting vulnerability for the development of unto
Externí odkaz:
https://doaj.org/article/c1d6d5e831bf4d768faa45f58b485950
Autor:
Marcus V. Andrade, Joao B Rezende-Neto, Sandro B. Rizoli, Mario Carvalho-Junior, Maria Julia Silva, Thiago A. Lisboa, José Renan Cunha-Melo, Gilberto P. Rodrigues
Publikováno v:
Journal of Surgical Research. 199:608-614
Preemptive treatment of trauma-associated coagulopathy involves transfusion of fresh frozen plasma (FFP) at 1:1 ratio with red blood cells (RBCs), but the optimal ratio remains controversial. In combat theaters, fresh whole blood (FWB) is also an opt
Publikováno v:
Anesthesia & Analgesia. 128:e54-e55
Autor:
Sandro Scarpelini, Shawn G. Rhind, Homer Tien, Fernando A. C. Spencer Netto, Kevin K. Leung, Sandro B. Rizoli
Publikováno v:
Journal of Organ Dysfunction. 4:99-105
Hypertonic saline (HS) is a promising fluid resuscitation therapy with the potential to reduce lung injury caused by severe trauma. The experimental evidence that HS has hemodynamic, anti-inflammatory, immunological, and neuroprotective properties an
Autor:
Alex P Di Battista, John E Buonora, Shawn G Rhind, Michael Gary Hutchison, Andrew J Baker, Sandro B. Rizoli, Ramon eDiaz-Arrastia, Gregory P Mueller
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 6 (2015)
Frontiers in Neurology, Vol 6 (2015)
Background Blood biomarkers are valuable tools for elucidating complex cellular and molecular mechanisms underlying traumatic brain injury (TBI). Profiling distinct classes of biomarkers could aid in the identification and characterization of initial
Publikováno v:
Critical Care Clinics. 20:313-324
Anemia may be the most common illness of critically ill patients. The majority of critically ill patients are anemic at admission to the intensive care unit (ICU), and hemoglobin concentrations typically decline during the first 3 days of ICU stay. H
Autor:
Tara M, Mastracci, Mohit, Bhandari, Raman, Mundi, Sandro B, Rizoli, Bartolomeu A, Nascimento, Martin, Schreiber, M E, McKenzie
Publikováno v:
Canadian Journal of Surgery. 55:426-428
Question: In elderly patients with variable preoperative anemia and volume of blood loss during major noncardiac surgery, does intraoperative blood transfusion reduce the risk of perioperative death? Design: Retrospective cohort study. Data source: N
Publikováno v:
The Journal of Immunology. 161:6288-6296
Hypertonic resuscitation fluids are known to be effective in restoring circulating volume in the hypovolemic trauma patient. Previous studies have suggested that hypertonicity might exert effects on immune cells leading to an altered host response. T
Autor:
Neil R, McMullin, Charles E, Wade, John B, Holcomb, Tina G, Nielsen, Rolf, Rossaint, Bruno, Riou, Sandro B, Rizoli, Yoram, Kluger, Philip I T, Choong, Brian, Warren, Bartholomew J, Tortella, Kenneth D, Boffard, G J, Dobb
Publikováno v:
The Journal of trauma. 69(1)
In trauma patients with significant hemorrhage, it is hypothesized that failure to normalize prothrombin time (PT) after recombinant activated factor VII (rFVIIa) treatment predicts poor clinical outcomes and potentially indicates a need for addition